Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Veltio Pharma AB
AB
Active
Org 5591612840
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 8 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Veltio Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
EBITDA
SEK millions
0M
-2M
-3M
-5M
-6M
0M
2021
-3M
-300%
2022
-3M
0%
2023
-3M
0%
2024
-5M
-67%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
78
282
Staff expenses
—
—
—
—
−2 758
EBITDA
−90
−2 937
−2 927
−2 671
−4 917
Depreciation & amort.
−0
−128
−199
−292
−343
EBIT
−90
−3 065
−3 126
−2 963
−5 259
Net financials
—
2
29
18
73
Profit before tax
−90
−3 063
−3 097
−2 945
—
Tax
−0
−0
−0
−0
—
Net profit
−90
−3 063
−3 097
−2 945
−5 187
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
727
1 650
2 001
2 306
5 740
Equity
636
1 271
1 174
1 739
5 009
Long-term debt
0
0
0
0
—
Short-term debt
91
379
826
567
731
Total debt
91
379
826
567
731
Financial ratios
5-year trend
EBITDA margin
-1742.3%
This company
15.8%
Market median
11127% below market
2021
2025
Equity ratio
87.3%
This company
38.2%
Market median
129% above market
2021
2025
Return on equity
-103.5%
This company
18.4%
Market median
663% below market
2021
2025
Net profit margin
-1837.9%
This company
8.1%
Market median
22790% below market
2021
2025
Asset turnover
0.05×
This company
1.12×
Market median
96% below market
2021
2025
Debt / equity
0.15×
This company
0.62×
Market median
76% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Veltio Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
